Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024

NASHVILLE, Tenn., Aug. 6, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced significantly improved financial results and a favorable overall company performance for the second quarter of 2024. Highlights include: $9.9 million in net revenue during the second quarter of 2024, an increase of 16$0.2 million, which represents a $0.8 million improvement over the prior period ...